Cited 1 times in
Real-World Study of Systemic Treatment after First-Line Atezolizumab plus Bevacizumab for Hepatocellular Carcinoma in Asia-Pacific Countries
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.